Neuca SA
WSE:NEU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.3), the stock would be worth zł831.8 (15% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | zł723 |
0%
|
| 3-Year Average | 0.3 | zł831.8 |
+15%
|
| 5-Year Average | 0.3 | zł869.3 |
+20%
|
| Industry Average | 0.9 | zł2 691.78 |
+272%
|
| Country Average | 1.5 | zł4 286.1 |
+493%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
zł3.2B
|
/ |
Jan 2026
zł13.6B
|
= |
|
|
zł3.2B
|
/ |
Dec 2026
zł14.1B
|
= |
|
|
zł3.2B
|
/ |
Dec 2027
zł14.7B
|
= |
|
|
zł3.2B
|
/ |
Dec 2028
zł15.1B
|
= |
|
|
zł3.2B
|
/ |
Dec 2029
zł16.6B
|
= |
|
|
zł3.2B
|
/ |
Dec 2030
zł17.4B
|
= |
|
|
zł3.2B
|
/ |
Dec 2031
zł18.2B
|
= |
|
|
zł3.2B
|
/ |
Dec 2032
zł18.9B
|
= |
|
|
zł3.2B
|
/ |
Dec 2033
zł19.6B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
N
|
Neuca SA
WSE:NEU
|
3.2B PLN | 0.3 | 20.7 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 0.3 | 23.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 0.2 | 36.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 0.2 | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 2.9 | 35.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.3 | 11.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.7 | 20.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.9 | 21.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.5 |
| 70th Percentile | 3.3 |
| Max | 491.2 |
Other Multiples
Neuca SA
Glance View
NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
